Protocols are often developed with little to no involvement of supply chain personnel. Though this is understandable – lack of assumptions, focus on clinical trial success before supply chain efficiency – alternatives at the trial design phase may make a difference of millions of dollars on the supply chain budgets! Changes that will not impact other essential aspects of the clinical trial, like patient comfort and compliance, or validity of the statistical design!
With a only a few days of consulting to look into a protocol and other key aspects of the clinical trial design, Belenox can identify those opportunities. Further involvement is possible to facilitate the implementation of selected recommendations.